Alexandre Calon

📢 Our paper is out! We define CTHRC1-CAFs as #biomarker of response to #immunotherapy in MSS and MSI #CRC Great teamwork @CalonLab @BatlleLab @mariglesiascoma Thanks @ContraCancerEs for their support 🔗 gut.bmj.com/content/early/…

🧵We’re thrilled to share our latest collaborative work with the José Yélamos group and collaborators, now published in @ScienceAdvances! We uncover a previously unrecognized role for PARP2 in pancreatic cancer (PDAC) progression, showing that its loss impairs tumour growth.👇

📢 Our paper is out! We define CTHRC1-CAFs as #biomarker of response to #immunotherapy in MSS and MSI #CRC Great teamwork @CalonLab @BatlleLab @mariglesiascoma Thanks @ContraCancerEs for their support 🔗 gut.bmj.com/content/early/…

🔬What if we could predict who will respond to immunotherapy in colorectal cancer? 🧬New biomarker (CTHRC1) led by @Calon_Alex @HMar_research & @BatlleLab @IRBBarcelona 👩‍⚕️With @ClaraMontagut & @mariglesiascoma 📊Read the full article: hospitaldelmar.cat/en/noticies/vi… @hmarpath @CIBER_ISCIII

🔬CTHRC1 identified as key biomarker in colorectal cancer 🧬Led by @Calon_Alex @HMar_research & @BatlleLab @IRBBarcelona 📊Validated in ~3,000 patients 🧪With @ClaraMontagut & @mariglesiascoma 👉Study: researchmar.net/news/view.php?… @hmarpath @CIBER_ISCIII

📢 Published in @Gut_BMJ! We define CTHRC1-CAFs as a #biomarker of clinical outcome and response to #immunotherapy in MSS and MSI #colorectal #cancer. gut.bmj.com/content/early/… @mariglesiascoma @Calon_Alex @BatlleLab @ClaraMontagut @hospitaldelmar @HMar_research @IRBBarcelona

La revista @Nature selecciona un estudi liderat per @PNavarro_Lab com un dels sis més destacats de l’any en #càncerdepàncrees 👉researchmar.net/noticies/1417/… #TalentMAR @CancerCSIC @iibbcsic

La Fundació ”la Caixa” atorga una ajuda a un projecte liderat pel Dr. @Calon_Alex Un projecte per avançar en el coneixement de l'entorn tumoral en #càncercòlon i recte @CanalUGR @uniovi_info @cnag_eu #HealthResearch #FundaciólaCaixa researchmar.net/noticies/1403/…

⭐️La Fundació ”la Caixa” atorga una ajuda de prop 1M€ per a un projecte de càncer de còlon amb participació del CNAG! La iniciativa està liderada pel Dr. @Calon_Alex (@HMar_research), amb suport d'organismes com @CanalUGR i @uniovi_info researchmar.net/noticies/1403/… #FundaciólaCaixa

La Fundación ”la Caixa” otorga una ayuda a un proyecto liderado por el Dr. @Calon_Alex Pretende avanzar en el conocimiento del entorno tumoral en #cáncercolon y recto @CanalUGR @uniovi_info @cnag_eu @CaixaResearchCA #HealthResearch #FundaciónlaCaixa hospitaldelmar.cat/ca/noticies/vi…

imim.cat/news/776/the-l… #HealthResearch #FundaciónlaCaixa

💡Chemists, physicists, biologists, clinicians, and computational scientists — 4 teams, one vision: bringing new hope to people facing colorectal cancer. Thanks to @FundlaCaixa / Health Research Call 2025. @CanalUGR @uniovi_info @cnag_eu @CaixaResearch @HMar_research

⚫Si eres médico e investigas en cáncer, ASEICA-Med es tu comunidad 📽️Te lo cuenta @JLinaresA (@hospitaldelmar) Te esperamos en el RETREAT #ASEICAMed 📅7OCT 🏟️Bilbao-San Mames ‼️ Posibilidad de Registro único o a todo el #ASEICACongress aseica.es/aseicamed-retr…

🔥Just out in @NatureCancer! ✅ TAV16, our tumor-agnostic WES-based assay, ranks among the best for MRD detection. ✅ Immune evasion as the main driver progression in MSS CRC, opening new avenues for ICIs. 🙏@_SEOM @GrupoTTD @SaludISCIII @GVAclinic nature.com/articles/s4301…

🧑‍🔬Identifican un nuevo factor que determina la agresividad del cáncer de páncreas 👩‍🔬Equipos del @iibbcsic y el @HMar_research demuestran el papel clave de una proteína en el núcleo de las células que rodean el tumor 👉 tiny.cc/rllg001

🚨 We'are thrilled to share our last study in colab with @gabyrabi, Juan L. Iovanna & @MFZlab that reveals a nuclear role for Galectin-1 (Gal1) in pancreatic stellate cells (PSCs), directly regulating KRAS expression and reshaping the PDAC stroma. A thread! 🧵👇 @PNASNews #PDAC

Les ajudes a la #recerca de @ContraCancerBCN han seleccionat 3 projectes de @HMar_research, liderats per Lluís Espinosa, @JLinaresA i @ClaraMontagut També un projecte @IRBBarcelona amb participació de la Dra. @SoniaServitja #CancerResearch #TalentMAR hospitaldelmar.cat/ca/noticies/vi…

🚨 New publication from our lab! A fantastic collaboration between @HMar_research and @IBECBarcelona

Paper alert! 📢 With the @XavierTrepat lab, we have developed MIRO, an #invitro platform to recreate #Cancer cells interactions with their microenvironment to test new #Immunotherapy strategies. nature.com/articles/s4146… @HMar_research @hospitaldelmar @IBECBarcelona @NatureComms